Glycemic outcomes of children 2–6 years of age with type 1 diabetes during the pediatric MiniMed™ 670G system trial

BACKGROUND: Highly variable insulin sensitivity, susceptibility to hypoglycemia and inability to effectively communicate hypoglycemic symptoms pose significant challenges for young children with type 1 diabetes (T1D). Herein, outcomes during clinical MiniMed™ 670G system use were evaluated in childr...

Descripción completa

Detalles Bibliográficos
Autores principales: Forlenza, Gregory P., Ekhlaspour, Laya, DiMeglio, Linda A., Fox, Larry A., Rodriguez, Henry, Shulman, Dorothy I., Kaiserman, Kevin B., Liljenquist, David R., Shin, John, Lee, Scott W., Buckingham, Bruce A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons A/S 2022
Materias:
Clinical Care and Technology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304187/
https://www.ncbi.nlm.nih.gov/pubmed/35001477
http://dx.doi.org/10.1111/pedi.13312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304187/
https://www.ncbi.nlm.nih.gov/pubmed/35001477
http://dx.doi.org/10.1111/pedi.13312

Ejemplares similares